| Market Capitalization (Millions $) |
196 |
| Shares
Outstanding (Millions) |
37 |
| Employees |
61 |
| Revenues (TTM) (Millions $) |
6 |
| Net Income (TTM) (Millions $) |
-283 |
| Cash Flow (TTM) (Millions $) |
-8 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
Armata Pharmaceuticals Inc is a biotechnology company that focuses on the discovery and development of bacteriophage-based therapeutics for the treatment of antibiotic-resistant bacterial infections. Bacteriophages are viruses that can specifically target and kill bacterial cells, making them a promising alternative to traditional antibiotics.
The company utilizes its proprietary phage-based platform to identify and engineer phages that can effectively eradicate antibiotic-resistant bacteria. Their goal is to develop phage-based therapies that can address the urgent global health challenge of antibiotic resistance.
Armata Pharmaceuticals Inc has a diverse pipeline of product candidates targeting various bacterial infections, including lung infections caused by Pseudomonas aeruginosa, as well as infections caused by other multidrug-resistant bacteria. They conduct rigorous clinical trials to demonstrate the safety and efficacy of their phage-based therapies.
Through their innovative approach, Armata Pharmaceuticals Inc aims to provide much-needed solutions for patients suffering from antibiotic-resistant infections, for which limited treatment options are currently available.
Company Address: 5005 McConnell Avenue Los Angeles 90066 CA
Company Phone Number: 665-2928 Stock Exchange / Ticker: NYSEAMER ARMP
|
0.21% 
100 %